|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROSCIENCE |
Departments of
1 Anesthesiology
2 Psychiatry
3 Molecular Biology and Pharmacology, Washington University School of Medicine, St Louis, MO 63110, USA
Neurosteroids are potent modulators of GABA-A receptors. We have examined the time course of development of potentiation of
1β2
2L GABA-A receptors during coapplication of GABA and an endogenous neurosteroid (3
,5
)-3-hydroxypregnan-20-one (3
5
P). The simultaneous application of 3
5
P with 5 µM GABA resulted in a biphasic rising phase of current with time constants of 50–60 ms for the rapid phase and 0.3–3 s for the slow phase. The properties of the rapid phase were similar at all steroid concentrations but the time constant of the slower phase became successively shorter as the steroid concentration was increased. Potentiation developed very rapidly (
= 130 ms) when cells were preincubated with 300 nM 3
5
P before application of GABA + 3
5
P, and in outside-out patch recordings, suggesting that steroid diffusion to intracellular compartments competes with receptor potentiation by depleting the cell membrane of steroid. Very low steroid concentrations (3–5 nM) potentiated GABA responses but the effects took minutes to develop. Intracellular accumulation of a fluorescent steroid analogue followed a similar time course, suggesting that slow potentiation results from slow accumulation within plasma membrane rather than indirect effects, such as activation of second messenger systems. In cell-attached single-channel recordings, where 3
5
P is normally applied through the pipette solution, addition of steroid to the bath solution dramatically shifted the steroid potentiation concentration–effect curve to lower steroid concentrations. We propose that bath-supplied steroid compensates for the diffusion of pipette-supplied steroid out of the patch to the rest of the cell membrane and/or intracellular compartments. The findings suggest that previous studies overestimate the minimum concentration of steroid capable of potentiating GABA actions at GABA-A receptors. The results have implications for the physiological role of endogenous neurosteroids.
(Received 9 August 2007;
accepted after revision 28 August 2007;
first published online 30 August 2007)
Corresponding author G. Akk: Department of Anesthesiology, Washington University School of Medicine, Campus Box 8054, 660 South Euclid Avenue, St Louis, MO 63110, USA. Email: akk{at}morpheus.wustl.edu
This article has been cited by other articles:
![]() |
G. Akk, P. Li, J. Bracamontes, D. E. Reichert, D. F. Covey, and J. H. Steinbach Mutations of the GABA-A Receptor {alpha}1 Subunit M1 Domain Reveal Unexpected Complexity for Modulation by Neuroactive Steroids Mol. Pharmacol., September 1, 2008; 74(3): 614 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Agis-Balboa, G. Pinna, F. Pibiri, B. Kadriu, E. Costa, and A. Guidotti Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice PNAS, November 20, 2007; 104(47): 18736 - 18741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |